Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Personalized Prophylaxis with Nuwiq in Severe Haemophilia A
NCT02256917Phase 3Completed
- Sponsor
- Octapharma
- Start
- May 2015
- Primary completion
- Sep 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 9
01
Overview
A Phase 3 trial of simoctocog alfa in hemophilia A, sponsored by Octapharma. Started May 2015; status: completed.
02
Drugs
simoctocog alfa
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT02256917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02256917.